Oxolinic acid is a quinolone antibiotic that was developed in Japan in the 1970s. It acts by inhibiting the enzyme DNA gyrase, which is essential for bacterial DNA replication.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 14698-29-4
Nalidixic acid
quinolone antibiotic active pharmaceutical ingredient
DIPHENHYDRAMINE HYDROCHLORIDE
active pharmaceutical ingredient
Cytarabine
active pharmaceutical ingredient
[1-(2-Phenylethyl)-1h-imidazol-2-yl]-4-piperidinylmethanone dihydrobromide
Alcaftadine impurity reference standard
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-2-yl)methanone
pharmaceutical active ingredient
SODIUM OXOLINATE
active pharmaceutical ingredient
5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
KYGZCKSPAKDVKC-UHFFFAOYSA-N
CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O